Acurx Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€12.17B +96,642.4% N/A -€8.96M +5.9% N/A
    €0.00 +NaN% -€12.57M +20.5% N/A -€8.45M +30.0% N/A
    €0.00 +NaN% -€10.43M -5.1% N/A -€6.51M +50.4% N/A
    €0.00 +NaN% -€11.00M +177.1% N/A -€4.33M +49.6% N/A
    €0.00 +NaN% -€3.97M -22.4% N/A -€2.89M -15.9% N/A
    €0.00 -€5.12M N/A -€3.44M N/A

    Notifications